Test study drugs to clear rickettsia infections
Treatments studied
Part of Infections clinical trials.
This study tests antibiotics to help your body clear rickettsia-related illnesses like murine typhus or scrub typhus. It may help reduce symptoms and shorten how long you feel sick, based on how well the infection clears.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You can safely take medicines by mouth (swallow pills/syrup).
- Your rapid test is positive for murine typhus or scrub typhus.
- You can stay in the hospital for at least 36 hours and return for follow-up visits.
- If you can become pregnant, your urine pregnancy test must be negative.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is tracking patients with a suspected or confirmed rickettsiosis infection, which is a bacterial disease spread by ticks. It aims to see how the illness progresses and how it is treated.
This trial compares two strong antibiotics, meropenem (given through a vein) and azithromycin (taken by mouth), to see which one works better for a hard-to-treat type of typhoid fever called XDR (extensively drug-resistant) enteric fever. If you have been diagnosed with XDR typhoid fever, this study aims to find the best treatment option for you.
This study is testing a new way to diagnose rickettsia infection, a bacterial disease spread by ticks. It looks at patients who have an eschar (a dark, scab-like sore at the tick bite site) or who have been asked to have a blood test for antibodies against the bacteria.
This study tests whether a single dose of the antibiotic doxycycline can prevent tick-borne relapsing fever, a disease spread by ticks that causes repeated fevers. It is for Air Force flight course cadets who are about to do outdoor field training.
This study tests whether a short course of a strong antibiotic (ceftriaxone) can help people who still have fatigue and other symptoms after being treated for Lyme disease. It aims to see if this treatment can improve your quality of life.
This study looks at how your body's immune system reacts to a tick bite. It may help doctors understand and prevent tick-borne diseases, which are illnesses spread by ticks, like Lyme disease.
Hear when a new Infectious Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.